NCT00587106View on ClinicalTrials.gov

Studies of Neurological Paraneoplastic Syndromes

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

April 30, 1988

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Paraneoplastic Neurologic Degenerations (PNDs)
Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00587106 - Studies of Neurological Paraneoplastic Syndromes | Biotech Hunter | Biotech Hunter